The global Veterinary Vaccines market was valued at US$ 8544.4 million in 2022 and is projected to reach US$ 12710 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Veterinary Vaccines market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Veterinary Vaccines market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Veterinary Vaccines market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune systems production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccines. This report contains market size and forecasts of Veterinary Vaccines in global, including the following market information:
- Global Veterinary Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.
We surveyed the Veterinary Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Vaccines Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Type, 2022 (%)
- Inactivated Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- DNA Vaccines
- Others
Global Veterinary Vaccines Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Application, 2022 (%)
- Veterinary Clinic
- Veterinary Hospital
- Veterinary Research Institute
- Retail Pharmacy
- Others
Global Veterinary Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Veterinary Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Veterinary Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Veterinary Vaccines revenues share in global market, 2022 (%)
key players include:
- Elanco
- Merck
- Merial
- Zoetis
- Advaxis
- AmpliPhi Biosciences
- Aratana Therapeutics
- ARKO Labs
- Bayer
- CanFel Therapeutics
- Ceva Animal Health
- Colorado Serum
- Epitopix
- Genus
- Hygieia Biological Laboratories
- ImmuCell
- Nexvet
- Nuovo Biologics
- UBI
- Valneva
- Vetoquinol
- Virbac
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Vaccines, market overview.
Chapter 2: Global Veterinary Vaccines market size in revenue.
Chapter 3: Detailed analysis of Veterinary Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
